Diabetes Complications

Company announces publication of results of diabetic foot ulcer clinical trial

Published in Obesity and Diabetes Week, September 26th, 2005

Celleration, Inc., announced the publication of the results of an important clinical study, "Ultrasound Therapy for Recalcitrant Diabetic Foot Ulcers," a randomized, double-blinded, sham-controlled, multicenter study.

The study was conducted in hospital-based and private wound-care clinics and demonstrated the increased incidence of wound closure of diabetic foot ulcers when treated with the MIST therapy system as compared to a sham control. These findings were published by William J, Ennis, DO, medical director of the wound treatment program, Advocate Christ Medical Center, Oak Lawn, Illinois, the lead investigator in the study published in the August issue of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2005-09-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry